Fundraising Fox

CellType

YC W26

New York City, US · Founded 2025 · 2 employees · Hiring · 3 known investors

CellType uses AI agents and biological models to automate drug discovery, having identified a novel cancer treatment signal and partnering with major pharmaceutical companies.

Also known as Contextual Bio

BiotechHealthtechUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (W26)

CellType was founded in 2025 by David van Dijk and Ivan Vrkic.

DVDavid van Dijk
David van Dijkin𝕏Co-Founder & CEODavid van Dijk holds a position as professor at Yale and has contributed to biological foundation models research. He is co-founder and CEO of CellType.
IVIvan Vrkic
Ivan VrkicinCo-FounderHe studied machine learning at Yale and EPFL, contributed to Cell2Sentence research published at ICML, and previously led foundation model training at a biotech startup and developed software for CERN's Large Hadron Collider.

Investors · 3

Competitors · 2

by search overlap

Companies competing with CellType for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does CellType do?
CellType uses AI agents and biological models to automate drug discovery, having identified a novel cancer treatment signal and partnering with major pharmaceutical companies.
Who founded CellType?
CellType was founded by David van Dijk, Ivan Vrkic in 2025.
Who are CellType's investors?
CellType's investors include ACVC Partners, Y Combinator, ZAKA VC.
Where is CellType headquartered?
CellType is headquartered in New York City, US.